Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

References

• Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325–328. doi: 10.1016/j.chom.2020.02.001
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565–574. doi: 10.1016/S0140-6736(20)30251-8
   PubMed Web of Science ®Google Scholar
• Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;10:1126.
   Google Scholar
• Gallagher TM, Buchmeier MJ. Coronavirus spike proteins in viral entry and pathogenesis. Virology. 2001;279(2):371–374. doi: 10.1006/viro.2000.0757
   PubMed Web of Science ®Google Scholar
• Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3(1):237–261. doi: 10.1146/annurev-virology-110615-042301
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhang Z, Chen W, et al. Predicting the receptor-binding domain usage of the coronavirus based on kmer frequency on spike protein. Infect Genet Evol. 2018;61:183–184. doi: 10.1016/j.meegid.2018.03.028
   PubMed Web of Science ®Google Scholar
• McBride R, van Zyl M, Fielding BC. The coronavirus nucleocapsid is a multifunctional protein. Viruses. 2014;6(8):2991–3018. doi: 10.3390/v6082991
   PubMed Web of Science ®Google Scholar
• Verheije MH, Hagemeijer MC, Ulasli M, et al. The coronavirus nucleocapsid protein is dynamically associated with the replication-transcription complexes. J Virol. 2010;84(21):11575–9. doi: 10.1128/JVI.00569-10
   PubMed Web of Science ®Google Scholar
• Chang CK, Hou MH, Chang CF, et al. The SARS coronavirus nucleocapsid protein–forms and functions. Antiviral Res. 2014;103:39–50. doi: 10.1016/j.antiviral.2013.12.009
   PubMed Web of Science ®Google Scholar
• Chang D, Lin M, Wei L, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020;323(11):1092–1093. doi: 10.1001/jama.2020.1623
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Resp Med. 2020;8(4):420–422. doi: 10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang J, Yang Y, et al. The potential role of IL-6 in monitoring severe case of coronavirus disease 2019. medRxiv preprint. 2020. doi: 10.1101/2020.03.01.20029769
   Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Wölfel R, Victor MC, Wolfgang G, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. doi:10.1038/s41586-020-2196-x (2020).
   Web of Science ®Google Scholar
• Liu W, Liu L, Kou G, et al. Evaluation of nucleocapsid and spike protein-based ELISAs for detecting antibodies against SARS-CoV-2. J Clin Microbiol. 2020. doi: 10.1128/JCM.00461-20
   Web of Science ®Google Scholar
• Liu W, Lu Y, Zhang J, et al. Viral kinetics and antibody responses in patients with COVID-19. medRxiv preprint. 2020. doi: 10.1101/2020.03.24.20042382
   Google Scholar
• Okba NMA, Müller MA, Li W, et al. Severe acute respiratory syndrome coronavirus 2−specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis. 2020. doi: 10.3201/eid2607.200841
   Web of Science ®Google Scholar
• Xiang F, Wang X, He X, et al. Antibody detection and dynamic characteristics in patients with COVID-19. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa461
   Web of Science ®Google Scholar
• Feng Y, Li C, Hu P, et al. An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques. Emerg Microbes Infect. 2018;7(1):101. doi: 10.1038/s41426-018-0102-5
   PubMed Web of Science ®Google Scholar
• Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa310
   Web of Science ®Google Scholar
• To KK-W, Tsang OT-Y, Leung W-S, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020. doi: 10.1016/S1473-3099(20)30196-1
   Web of Science ®Google Scholar
• Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa344
   Web of Science ®Google Scholar
• Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–389. doi: 10.1080/22221751.2020.1729071
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Resp Med. 2020. doi: 10.1016/S2213-2600(20)30079-5
   Web of Science ®Google Scholar
• Garoff H, Hewson R, Opstelten DJ, et al. Virus maturation by budding. Microbiol Mol Biol Rev. 1998 Dec;62(4):1171–1190. doi: 10.1128/MMBR.62.4.1171-1190.1998
   PubMed Web of Science ®Google Scholar
• Chan PK, Liu EY, Leung DT, et al. Evaluation of a recombinant nucleocapsid protein-based assay for anti-SARS-CoV IgG detection. J Med Virol. 2005;75(2):181–184. doi: 10.1002/jmv.20254
   PubMed Web of Science ®Google Scholar
• Liang FY, Lin LC, Ying TH, et al. Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection. J Virol Methods. 2013;187(2):413–420. doi: 10.1016/j.jviromet.2012.11.009
   PubMed Web of Science ®Google Scholar
• Leung DT, Tam FC, Ma CH, et al. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis. 2004;190(2):379–386. doi: 10.1086/422040
   PubMed Web of Science ®Google Scholar
• Buchholz UJ, Bukreyev A, Yang L, et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci U.S.A.. 2004;101(26):9804–9809. doi: 10.1073/pnas.0403492101
   PubMed Web of Science ®Google Scholar